Navigation Links
Two Of The Nation's Top Specialists In Lupus, Drs. Swamy Venuturupalli & Daniel Wallace, Join In Expanding Research On Auto-Immune Diseases
Date:4/1/2013

BEVERLY HILLS, Calif., April 1, 2013 /PRNewswire/ -- In a new association of nationally renowned specialists on Lupus and auto-immune disorders, Dr. Swamy Venuturupalli , is joining with Dr. Daniel Wallace to accelerate research into those diseases along with their expanded clinical practice. The two noted clinician scientists will base an aggressive and well-funded study program out of "The Wallace Rheumatic Diseases Research Center" in West Hollywood, CA. Dr. Venuturupalli established a strong Lupus research and public education program over the past ten years in his group practice with Beverly Medical Associates.

(Photo: http://photos.prnewswire.com/prnh/20130401/LA85971)

"The last several decades have expanded our understanding of the genetic and molecular causes of autoimmune diseases. This information now has to be applied to the care of patients suffering from these conditions, and that will be the focus of the next decade," explains Dr. Venuturupalli.  He notes that the move coincides with his desire for growth in the areas of patient education and autoimmune disease research and widens the service of their respective infusion centers.

In addition to evolving his clinical practice in the areas of lupus, autoimmune and inflammatory diseases, Dr. Venuturupalli notes that the association will continue to teach and lecture on a wide variety of health topics. Dr. Venuturupalli explains his philosophy simply, "As a physician, I believe that every case is unique, and how lupus affects one person is vastly different than how it affects another. It has been my endeavor to try and understand each individual patient and tailor my approach to their particular illness."

"Dr. Venuturupalli is an inspiration," comments Kathy Ireland CEO of kathy ireland Worldwide (kiWW) who has addressed part of her health activism to the progress of knowledge in auto-immune concerns.  "His commitment to the battle against Lupus and his leadership and knowledge in the pivotal role of managing inflammation is a pathway to better living for people everywhere."

Kathy Ireland is recognized as one of the top 10 Women's Health Advocates in America. Today, kiWW confirmed plans to collaborate with Dr. Venuturupalli on making critical information available on Lupus and the role of inflammation in health and wellness.

Dr. Venutrupalli states that he finds he is able to reach only a limited number of individuals through his practice and wants to find ways to educate patients about the advances in care for lupus and related disorders. He has taken to the web in order to achieve this. He is the featured expert on the WebMD Lupus Support Group (http://exchanges.webmd.com/lupus-exchange) and uses his website to disseminate tips on healthy living and exercise.

The move to collaborate with Dr. Wallace will allow both doctors to have access to each others' patients and provide a superior level of care for autoimmune diseases, which can sometimes be serious and life threatening. "Having collaborated with Dr. Venuturupalli on many clinical trials, this move is perfect synergy," says Dr. Wallace.

About Dr. Swamy Venuturupalli

Dr. R Swamy Venuturupalli is a board-certified rheumatologist practicing in Los Angeles. He is Clinical Chief of the Division of Rheumatology at Cedars Sinai Medical Center as well as Associate Clinical Professor of Medicine at UCLA. In addition he is Editor-in-Chief of Current Rheumatology Reports.

Dr. Venuturupalli's role as research investigator includes over a hundred clinical trials. He conducted research on complementary and alternative medicine, publishing studies on Ayurvedic medicine, dietary supplements, and mind-body medicine. He participates in ongoing rheumatology research at the Cedars Sinai Division of Rheumatology and has authored numerous text-book chapters.

For the past ten years, Dr. Venuturupalli has held a private practice in association with a group of rheumatologists.  Dr. Venuturupalli is married with 2 children. His wife; also a physician, is Medical Director for Womens' health in Los Angeles county.


'/>"/>
SOURCE Dr. Swamy Venuturupalli
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Next-Generation Drug-Device Combinations Provide Innovative Delivery Methods for the Growing Biologics Market
2. SynCardias 50cc Total Artificial Heart Receives Two HUD Designations from the FDA for Destination Therapy and Pediatric Bridge to Transplant
3. Ibrutinib Receives Two Oncology Breakthrough Therapy Designations from U.S. Food and Drug Administration
4. Takeda Receives FDA Approval for Three New Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations OSENI (alogliptin and pioglitazone) and KAZANO (alogliptin and metformin HCl)
5. Nearly Half of Children Under 2 Years of Age Receive Some Vaccinations Late
6. BI-LO Offers Health Giveaways With Flu Vaccinations, Encourages Community To Shield Their Health This Flu Season
7. NationsHealth, Inc. Boosts Arizona Economy With Business Expansion
8. MLB All-Star Pitcher CC Sabathia Issues Fast Relief Challenge to Generate Donations for the American Red Cross
9. Nominations Open for San Francisco Business Times Health Care Heroes Awards
10. Central Nervous System Drug Delivery Specialists
11. Imaging Healthcare Specialists Among the First in the Nation to Offer Imaging Diagnosis for Alzheimers Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... 26, 2016   Change Healthcare , ... network solutions and technology-enabled services designed to ... into a strategic channel partnership with SourceMed, ... solutions and revenue cycle management services that ... rehabilitation clinics to optimize revenue, operational efficiency ...
(Date:5/25/2016)... FDA 510(k) clearance covers Confocal Miniprobes ... and surgical applications Mauna Kea Technologies ... multidisciplinary confocal laser endomicroscopy (CLE) platform, today announced ... the 12 th 510(k) clearance from United ... FDA clearance covers Confocal Miniprobes indicated for use ...
(Date:5/25/2016)... Deutschland und GERMANTOWN, Maryland , ... Zusammenarbeit mit Therawis bedient dringenden ...   QIAGEN N.V. (NASDAQ: ... bekannt, eine Lizenz- und Entwicklungsvereinbarung mit Therawis Diagnostics ... die Onkologie eingegangen zu sein. Ein erstes Projekt ...
Breaking Medicine Technology:
(Date:5/31/2016)... MN (PRWEB) , ... May 31, 2016 , ... DDL, ... the American Association for Laboratory Accreditation (A2LA) to include ISO 594-1 and ISO 594-2 ... common means of achieving a leak-free connection between two medical devices (e.g. a syringe ...
(Date:5/31/2016)... ... May 31, 2016 , ... Like jewels in a crown, the multiple awards ... is home to Ontario’s leading day spa and one of Canada’s few accredited 5 ... a unique concept to combine spa services with hair and beauty services ...
(Date:5/31/2016)... ... May 31, 2016 , ... The Orthopaedic Research and Education Foundation (OREF) ... David G. Lewallen, MD, began his term as president in March, succeeding John J. ... is OREF’s new president-elect. Richard F. Kyle, MD, will serve as chair, corporate development, ...
(Date:5/31/2016)... ... May 31, 2016 , ... ... 2016 Cool Vendors in Security Infrastructure Protection report by Gartner1 Inc. , Each ... series of research reports evaluating these innovative vendors and their products and services. ...
(Date:5/31/2016)... , ... May 31, 2016 , ... Super Powder, a ... to on the go individuals and dedicated athletes, continues to transform the nutritional supplement ... with whey, pea and milk protein, branched-chain amino acids (BCAA), alkaline minerals, wheat grass, ...
Breaking Medicine News(10 mins):